Akums Drugs and Pharmaceuticals Limited (BOM:544222)
India flag India · Delayed Price · Currency is INR
450.65
-13.70 (-2.95%)
At close: Feb 13, 2026

BOM:544222 Statistics

Total Valuation

BOM:544222 has a market cap or net worth of INR 69.10 billion. The enterprise value is 53.66 billion.

Market Cap 69.10B
Enterprise Value 53.66B

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date Feb 13, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 153.10M
Shares Outstanding n/a
Shares Change (YoY) +4.01%
Shares Change (QoQ) -0.11%
Owned by Insiders (%) 35.44%
Owned by Institutions (%) 17.10%
Float 30.35M

Valuation Ratios

The trailing PE ratio is 21.72 and the forward PE ratio is 19.80.

PE Ratio 21.72
Forward PE 19.80
PS Ratio 1.60
PB Ratio 2.18
P/TBV Ratio 2.20
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 16.86
EV / Sales 1.24
EV / EBITDA 10.00
EV / EBIT 14.12
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.03
Debt / EBITDA 0.17
Debt / FCF n/a
Interest Coverage 5.39

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 22.88%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 5.73M
Profits Per Employee 422,229
Employee Count 7,536
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, BOM:544222 has paid 113.60 million in taxes.

Income Tax 113.60M
Effective Tax Rate 3.38%

Stock Price Statistics

The stock price has decreased by -18.00% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -18.00%
50-Day Moving Average 439.67
200-Day Moving Average 485.30
Relative Strength Index (RSI) 52.39
Average Volume (20 Days) 4,648

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:544222 had revenue of INR 43.19 billion and earned 3.18 billion in profits. Earnings per share was 20.78.

Revenue 43.19B
Gross Profit 17.60B
Operating Income 3.80B
Pretax Income 3.36B
Net Income 3.18B
EBITDA 5.36B
EBIT 3.80B
Earnings Per Share (EPS) 20.78
Full Income Statement

Balance Sheet

The company has 16.54 billion in cash and 902.87 million in debt, with a net cash position of 15.64 billion.

Cash & Cash Equivalents 16.54B
Total Debt 902.87M
Net Cash 15.64B
Net Cash Per Share n/a
Equity (Book Value) 31.68B
Book Value Per Share 205.37
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 40.77%, with operating and profit margins of 8.80% and 7.37%.

Gross Margin 40.77%
Operating Margin 8.80%
Pretax Margin 7.78%
Profit Margin 7.37%
EBITDA Margin 12.42%
EBIT Margin 8.80%
FCF Margin n/a

Dividends & Yields

BOM:544222 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.01%
Shareholder Yield -4.01%
Earnings Yield 4.60%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2